Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway

Cisplatin has been used effectively in the treatment of hepatocellular carcinoma (HCC). Long noncoding RNAs (lncRNAs) were recently reported to contribute to the pathogenesis and progression of HCC. Their molecular mechanism related to cisplatin treatment remains unclear. The purpose of this study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ping, Cui, Jiayue, Wen, Jihong, Guo, Yunhui, Zhang, Liangzi, Chen, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228559/
https://www.ncbi.nlm.nih.gov/pubmed/28105167
http://dx.doi.org/10.3892/ol.2016.5288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228559/
https://www.ncbi.nlm.nih.gov/pubmed/28105167
http://dx.doi.org/10.3892/ol.2016.5288

Ejemplares similares